6-paradol and 6-gingerol (active compounds) activate transient receptor potential channels (TRPV1 and TRPA1) on sensory neurons. These "heat sensors" send signals to the sympathetic nervous system, which activates brown adipose tissue (BAT) via β3-adrenergic receptor stimulation. Activated BAT expresses uncoupling protein 1 (UCP1), which uncouples the mitochondrial electron transport chain — dissipating the proton gradient as HEAT instead of ATP. This "futile cycling" burns calories without producing useful energy — essentially turning fat into heat. GP achieves this without the oral burning sensation of capsaicin because 6-paradol is structurally different at the vanilloid-binding region.
No critical interactions identified.
No significant drug interactions documented.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.